PPP
ALT icon

Private Portfolio Partners’s Altimmune ALT Stock Holding History

Private Portfolio Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$105K Buy
14,500
+300
+2% +$2.29K 0.02% 297
2024
Q3 		$87.2K Buy
14,200
+2,600
+22% +$17.6K 0.02% 292
2024
Q2 		$77.1K Buy
+11,600
New +$85.6K 0.06% 87

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Private Portfolio Partners's ALT Position: Q4 2024 in Review

Private Portfolio Partners increased its Altimmune (ALT) stake by 2.1% in Q4 2024, buying an estimated $2.29K and bringing the position to 14,500 shares worth $105K. The position accounts for 0.02% of the portfolio, ranked #297.

Private Portfolio Partners first reported a position in ALT in Q2 2024 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold ALT as of Q4 2024.

  • Private Portfolio Partners held 14,500 shares of Altimmune worth $105K as of Q4 2024.
  • Private Portfolio Partners bought 300 Altimmune shares in Q4 2024, an estimated $2.29K.
  • Altimmune made up 0.02% of Private Portfolio Partners's portfolio in Q4 2024, its #297 holding.
  • Private Portfolio Partners first reported a position in Altimmune in Q2 2024 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Altimmune as of Q4 2024.

Based on Private Portfolio Partners's 13F filing for Q4 2024, filed 12 Feb 2025.